Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,006,991
-$13,546 QoQ
Shares Held
3,965
-5.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.17%
of 13F equity value
Holder Rank
#3,014
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Centerpoint Advisors, LLC holds $2,533,470 across 10 Drug Manufacturers - General names. JNJ ranks #1 (39.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
3,965 | $1,006,991 | |
| 2 | LLY |
ELI LILLY & Co
|
817 | $979,934 | |
| 3 | ABBV |
AbbVie Inc.
|
1,182 | $297,438 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,035 | $132,997 | |
| 5 | PFE |
Pfizer Inc
|
3,152 | $75,900 | |
| 6 | BIIB |
Biogen Inc.
|
83 | $17,932 | |
| 7 | AMGN |
Amgen Inc
|
28 | $10,139 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
56 | $7,075 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,006,991 | 3,965 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,020,537 | 4,175 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,144,433 | 5,530 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,054,668 | 5,688 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $882,436 | 5,777 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $1,036,168 | 6,248 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,078,575 | 7,458 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $1,252,399 | 7,728 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,606,590 | 10,992 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,928,019 | 12,188 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $1,939,657 | 12,375 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $1,929,431 | 12,388 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $2,005,440 | 12,116 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $2,137,760 | 13,792 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $2,431,940 | 13,767 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $2,194,088 | 13,431 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $2,534,487 | 14,278 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $2,376,477 | 13,409 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $2,004,427 | 11,717 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $1,427,821 | 8,841 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $1,477,058 | 8,966 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $243,566 | 1,482 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $233,079 | 1,481 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $205,901 | 1,383 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $194,491 | 1,383 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $181,221 | 1,382 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||